<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01638832</url>
  </required_header>
  <id_info>
    <org_study_id>JWGUHMED1-005</org_study_id>
    <nct_id>NCT01638832</nct_id>
  </id_info>
  <brief_title>Association of Non-alcoholic Fatty Liver Disease and Coronary Artery Disease</brief_title>
  <official_title>Association of Non-alcoholic Fatty Liver Disease and Coronary Artery Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johann Wolfgang Goethe University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johann Wolfgang Goethe University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the association of non-alcoholic fatty liver disease and coronary
      artery disease. All patients presenting for coronary angiogram will receive the following
      examination:

        -  Transient Elastography and Controlled Attenuation Parameter using the FibroScan

        -  blood examination including biochemical markers The results of non-invasive liver
           steatosis and fibrosis measurement are compared with the results of coronary angiogram
           concerning the presence or absence of coronary artery disease.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2012</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">September 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Liver fibrosis scores I-IV (METAVIR)</measure>
    <description>METAVIR fibrosis scores:
I = mild fibrosis II = significant fibrosis III = advanced fibrosis IV = cirrhosis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Steatosis fibrosis scores I-III</measure>
    <description>Steatosis scores:
0 = &lt;5% I = 5-33% II = 33-66% III = &gt;66%</description>
  </secondary_outcome>
  <enrollment type="Anticipated">572</enrollment>
  <condition>Nonalcoholic Steatohepatitis (NASH)</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transient Elastography (FibroScan), Echosens, Paris, France</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Controlled Attenuation Parameter (CAP), Echosens, Paris, France</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female, 18 years and older

          -  Written consent

          -  Coronary angiogram planned

        Exclusion Criteria:

          -  Patients with mental diseases

          -  Pregnancy or lactation

          -  Ascites
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mireen Friedrich-Rust, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinikum der J. W. Goethe-Universität Frankfurt am Main</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mireen Friedrich-Rust, MD</last_name>
    <email>Mireen.Friedrich-Rust@kgu.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Klinikum der J. W. Goethe-Universität</name>
      <address>
        <city>Frankfurt am Main</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 5, 2012</study_first_submitted>
  <study_first_submitted_qc>July 11, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 12, 2012</study_first_posted>
  <last_update_submitted>July 11, 2012</last_update_submitted>
  <last_update_submitted_qc>July 11, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 12, 2012</last_update_posted>
  <keyword>NASH; coronary artery disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Fatty Liver</mesh_term>
    <mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

